ARTICLE | Clinical News
Wakix pitolisant regulatory update
December 7, 2015 8:00 AM UTC
EMA’s CHMP recommended approval of Wakix pitolisant from Bioprojet to treat narcolepsy with or without cataplexy. The product is a histamine H3 receptor (HRH3) antagonist. ...